Drugs / NBF-006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03819387 | Mar 2019 → Nov 2023 | colorectal cancer, malignant exocrine pancreas neoplasm, non-small cell lung carcinoma | Nitto BioPharma, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBF-006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03819387 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT03819387 ↗ |